ID: ALA433982

Max Phase: Preclinical

Molecular Formula: C22H27N7

Molecular Weight: 389.51

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2[nH]c(CN3CCNCCN(Cc4nc5ccccc5[nH]4)CC3)nc2c1

Standard InChI:  InChI=1S/C22H27N7/c1-2-6-18-17(5-1)24-21(25-18)15-28-11-9-23-10-12-29(14-13-28)16-22-26-19-7-3-4-8-20(19)27-22/h1-8,23H,9-16H2,(H,24,25)(H,26,27)

Standard InChI Key:  DKBVDTXZASJGTI-UHFFFAOYSA-N

Associated Targets(Human)

Cell line 371 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 389.51Molecular Weight (Monoisotopic): 389.2328AlogP: 2.35#Rotatable Bonds: 4
Polar Surface Area: 75.87Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.19CX Basic pKa: 9.59CX LogP: 1.67CX LogD: -0.33
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.06

References

1. Ji HF, Zhang HY..  (2005)  A new strategy to combat Alzheimer's disease. Combining radical-scavenging potential with metal-protein-attenuating ability in one molecule.,  15  (1): [PMID:15582403] [10.1016/j.bmcl.2004.10.047]

Source